Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 59

Results For "Covid"

1163 News Found

Pharmapack Europe awards winners 2022
Packaging | May 19, 2022

Pharmapack Europe awards winners 2022

Pharmapack Europe recognizes excellence and innovation from exhibitors across connected devices, sustainability, supply chain logistics, route of administration, and packaging innovation, as well from the wider industry for patient-centric design and eco-design


Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit
Public Health | May 19, 2022

Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit

This cost-effective tool will be of immense benefit to other high burden countries as well.


Cytel designed and led TOGETHER trial wins Clinical Trial award
News | May 18, 2022

Cytel designed and led TOGETHER trial wins Clinical Trial award

Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills


Singapore based Inspired Technology receives WHO certification
Medical Device | May 18, 2022

Singapore based Inspired Technology receives WHO certification

The latest certification endorses product for cold chain monitoring across 194 WHO member countries


Pfizer and BioNTech granted U.S. EUA for booster dose for kids 5-11 years
Drug Approval | May 18, 2022

Pfizer and BioNTech granted U.S. EUA for booster dose for kids 5-11 years

Children 5 through 11 years of age are now authorized to receive a booster dose at least five months after the second dose of the two-dose primary series


Themis Medicare gets add on approval for Viralex
Drug Approval | May 18, 2022

Themis Medicare gets add on approval for Viralex

Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties


BDR Pharma receives Rs. 685 crore of PE investment
News | May 17, 2022

BDR Pharma receives Rs. 685 crore of PE investment

Multiples is the first private equity (PE) investor in the company


Moderna announces advancements in mRNA platform science for application across multiple diseases
Biotech | May 17, 2022

Moderna announces advancements in mRNA platform science for application across multiple diseases

Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery


Biological E. reduces Corbevax price to Rs.250 a dose
News | May 16, 2022

Biological E. reduces Corbevax price to Rs.250 a dose

The move comes a few weeks after receiving the EUA for children between the ages of 5 and 12


Merck KGaA first quarter earnings grows on higher volumes, margins
News | May 15, 2022

Merck KGaA first quarter earnings grows on higher volumes, margins

Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter